FC
NOTV

Fairpointe Capital’s Inotiv NOTV Stock Holding History

Fairpointe Capital’s Portfolio NOTV Stock Details NOTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$1.01M Buy
+50,331
New +$782K 1.52% 17

Other funds holding NOTV

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Fairpointe Capital's NOTV Position: Q1 2021 in Review

Fairpointe Capital opened a new position in Inotiv (NOTV) in Q1 2021: 50,331 shares worth $1.01M. The stake represents 1.52% of the portfolio and ranks #17 among its holdings.

40 funds tracked by Wall St. Rank hold NOTV as of Q1 2021.

  • Fairpointe Capital held 50,331 shares of Inotiv worth $1.01M as of Q1 2021.
  • Inotiv was a new Fairpointe Capital position in Q1 2021.
  • Inotiv made up 1.52% of Fairpointe Capital's portfolio in Q1 2021, its #17 holding.
  • 40 funds tracked by Wall St. Rank held Inotiv as of Q1 2021.

Based on Fairpointe Capital's 13F filing for Q1 2021, filed 13 May 2021.